Literature DB >> 24727675

An aberrant microRNA signature in childhood T-cell lymphoblastic lymphoma affecting CDKN1B expression, NOTCH1 and growth factor signaling pathways.

L Mussolin1, A B Holmes2, C Romualdi3, G Sales3, E S G D'Amore4, M Ghisi5, M Pillon6, A Rosolen1, K Basso7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24727675     DOI： 10.1038/leu.2014.134

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.

Authors:  Su Jung Song; Keisuke Ito; Ugo Ala; Lev Kats; Kaitlyn Webster; Su Ming Sun; Mojca Jongen-Lavrencic; Katia Manova-Todorova; Julie Teruya-Feldstein; David E Avigan; Ruud Delwel; Pier Paolo Pandolfi
Journal:  Cell Stem Cell       Date:  2013-07-03       Impact factor: 24.633

Review 2.  Therapeutic targeting of platelet-derived growth factor receptors in solid tumors.

Authors:  Monika Ehnman; Arne Östman
Journal:  Expert Opin Investig Drugs       Date:  2013-11-11       Impact factor: 6.206

3.  T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.

Authors:  Katia Basso; Lara Mussolin; Antonella Lettieri; Manisha Brahmachary; Wei Keat Lim; Andrea Califano; Giuseppe Basso; Andrea Biondi; Giovanni Cazzaniga; Angelo Rosolen
Journal:  Genes Chromosomes Cancer       Date:  2011-08-30       Impact factor: 5.006

4.  A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).

Authors:  Konstantinos J Mavrakis; Joni Van Der Meulen; Andrew L Wolfe; Xiaoping Liu; Evelien Mets; Tom Taghon; Aly A Khan; Manu Setty; Manu Setti; Pieter Rondou; Peter Vandenberghe; Eric Delabesse; Yves Benoit; Nicholas B Socci; Christina S Leslie; Pieter Van Vlierberghe; Frank Speleman; Hans-Guido Wendel
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

5.  Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150.

Authors:  Margherita Ghisi; Alberto Corradin; Katia Basso; Chiara Frasson; Valentina Serafin; Subhamoy Mukherjee; Lara Mussolin; Katia Ruggero; Laura Bonanno; Alessandro Guffanti; Gianluca De Bellis; Gino Gerosa; Giovanni Stellin; Donna M D'Agostino; Giuseppe Basso; Vincenzo Bronte; Stefano Indraccolo; Alberto Amadori; Paola Zanovello
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

Review 6.  Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases?

Authors:  Birgit Burkhardt
Journal:  Br J Haematol       Date:  2009-11-24       Impact factor: 6.998

7.  Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway.

Authors:  Jun Yang; Xin Liu; Susan B Nyland; Ranran Zhang; Lindsay K Ryland; Kathleen Broeg; Kendall Thomas Baab; Nancy Ruth Jarbadan; Rosalyn Irby; Thomas P Loughran
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

8.  The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.

Authors:  Marc R Mansour; Takaomi Sanda; Lee N Lawton; Xiaoyu Li; Taras Kreslavsky; Carl D Novina; Marjorie Brand; Alejandro Gutierrez; Michelle A Kelliher; Catriona H M Jamieson; Harald von Boehmer; Richard A Young; A Thomas Look
Journal:  J Exp Med       Date:  2013-07-15       Impact factor: 14.307

9.  Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites.

Authors:  Doron Betel; Anjali Koppal; Phaedra Agius; Chris Sander; Christina Leslie
Journal:  Genome Biol       Date:  2010-08-27       Impact factor: 13.583

10.  Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia.

Authors:  Hamilton L Gimenes-Teixeira; Antonio R Lucena-Araujo; Guilherme A Dos Santos; Dalila L Zanette; Priscila S Scheucher; Luciana C Oliveira; Leandro F Dalmazzo; Wilson A Silva-Júnior; Roberto P Falcão; Eduardo M Rego
Journal:  Exp Hematol Oncol       Date:  2013-04-08
View more
  6 in total

1.  Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.

Authors:  Irene Vázquez-Domínguez; Laura González-Sánchez; Pilar López-Nieva; Pablo Fernández-Navarro; María Villa-Morales; María Á Cobos-Fernández; Isabel Sastre; Mario F Fraga; Agustín F Fernández; Marcos Malumbres; María Salazar-Roa; Osvaldo Graña-Castro; Javier Santos; Pilar Llamas; José L López-Lorenzo; José Fernández-Piqueras
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

Review 2.  Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.

Authors:  Rodney R Miles; Rikin K Shah; J Kimble Frazer
Journal:  Br J Haematol       Date:  2016-03-11       Impact factor: 6.998

3.  Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma.

Authors:  Elena Pomari; Federica Lovisa; Elisa Carraro; Simona Primerano; Emanuele S G D'Amore; Paolo Bonvini; Luca Lo Nigro; Rita De Vito; Luciana Vinti; Piero Farruggia; Marta Pillon; Giuseppe Basso; Katia Basso; Lara Mussolin
Journal:  Oncotarget       Date:  2017-11-11

4.  Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.

Authors:  David M Habiel; Nicolas Krepostman; Michael Lilly; Karen Cavassani; Ana Lucia Coelho; Takehiko Shibata; Kojo Elenitoba-Johnson; Cory M Hogaboam
Journal:  Oncotarget       Date:  2016-12-13

Review 5.  MiRNA Dysregulation in Childhood Hematological Cancer.

Authors:  Jaqueline Carvalho de Oliveira; Gabriela Molinari Roberto; Mirella Baroni; Karina Bezerra Salomão; Julia Alejandra Pezuk; María Sol Brassesco
Journal:  Int J Mol Sci       Date:  2018-09-10       Impact factor: 5.923

Review 6.  The many facets of miR-223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response.

Authors:  Andrea Favero; Ilenia Segatto; Tiziana Perin; Barbara Belletti
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-05-05       Impact factor: 9.957
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.